Who owns 14740B901 - CASCADIAN THERAPEUTICS INC - COM - Call based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CASCADIAN THERAPEUTICS INC - COM - Call Institutional Ownership

Q: What is CUSIP 14740B901?

CUSIP 14740B901 is the security identifier used in SEC filing datasets for 14740B901 - CASCADIAN THERAPEUTICS INC - COM - Call.

CUSIP: 14740B901

13F Institutional Holders and Ownership History from Q2 2016 to Q1 2017

Type / Class: Equity / COM

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 14740B901?
CUSIP 14740B901 identifies 14740B901 - CASCADIAN THERAPEUTICS INC - COM - Call in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 14740B901:

Q1 2017 (0 holders) Q4 2016 (0 holders) Q3 2016 (0 holders) Q2 2016 (0 holders)

Institutional Holders of CASCADIAN THERAPEUTICS INC - COM - Call across Reporting Periods

Period	Calls Notional Value	Price (Median)
2017 Q1	$0
2016 Q4	$447,000	$4.31
2016 Q3	$248,000	$6.70
2016 Q2	$82,000	$0.95